Cardiac CT's financial impact on the cardiovascular service line

 

An economic impact analysis of cardiac computed tomography (CTA) across the cardiovascular service line dispels some common myths about the limited use cases for CTA. MedAxiom, a division of the American College of Cardiology (ACC), presented its findings at the Society of Cardiovascular Computed Tomography (SCCT) 2023 meeting.

The cardiology professional services organization specializes in offering strategic and operational support to cardiovascular practices and healthcare systems. Its report confirmed that cardiac CT plays a significant role in cardiovascular care, spanning various patient populations and helping in such areas as chest pain workup, prevention and wellness assessments, electrophysiology, structural heart procedures and vascular disease diagnoses.

"As we started to take a look at the implementation of CT within cardiovascular care delivery, I think there were several myths that seemed to be fairly common. One is that CT has a very small portion of care delivery opportunities or use cases. But when you really start to look at where it fits within the patient populations that we deliver care to, it's actually a very significant portion of our patients that would deserve access to CT technology and imaging," explained Ginger Biesbrock, DSc, executive vice president of MedAxiom, who presented the "Financial Impact of Cardiac CT to the Cardiovascular Service Line" report at SCCT in July. 

CT is not replacing other cardiac imaging modalities 

One significant finding from MedAxiom's research was that cardiac CT did not replace other imaging modalities, but instead complemented them. It expanded the capacity to care for a broader patient population, enabling rapid diagnosis and earlier intervention. This approach resulted in increased patient throughput, as exemplified by the development of rapid chest pain pathway programs that diverted patients away from emergency departments and into cardiology practices.

"What they really found is that adding CT and using it appropriately increase their capacity to take care of a larger population of patients," Biesbrock said. 

She pointed to examples of two healthcare systems that are early adopters of outpatient, dedicated cardiac CT programs. They developed a rapid chest pain evaluation pathway at clinics within their cardiology practice using CT, rather than the usual presentation to an emergency department.

"So when you really look at those organizations, that took a very deliberate approach to utilizing CT and CTA in their programs. What they found was it was actual incremental growth, versus taking away from existing imaging modalities that were already in use. It allowed them to expand their capacity to take care of a larger, broader patient population than what they did prior," she said.

This trend was also found at nearly 20 other healthcare systems that are high-volume users of CTA.

"They really did not have a drop in their echo, stress echo or SPECT studies. What they had was a transition to patients for those studies that were more appropriate while using CT for that early diagnosis in those lower-acuity patients. Just as we see recommended in the guidelines," Biesbrock explained.  

Reimbursement concerns with cardiac CT

Despite cardiac CT receiving a class 1A recommendation in the 2021 ACC/AHA chest pain guidelines, there has not been a significant increase in reimbursement rates. However, organizations that embraced cardiac CT and  operate higher-volume programs were able to offset lower reimbursement through those increased patient volumes, making it a financially viable option, Biesbrock said. 

"Unfortunately, we haven't seen a big increase in CTA reimbursement ... but this is what's happening with programs with fairly high volumes through their CT: In a day they can take one CT camera and scan as many as 12 patients. If you apply that to your stress echo program or your SPECT program, that's almost twice as many patients as you'd be able to get through in a single camera for those other modalities," she explained. 

Although the reimbursement is less, MedAxiom feels the value of CTA is significant, and therefore reimbursement should match that value. 

Biesbrock emphasized the importance of choosing the right test for the right patient, which could also lead to higher reimbursement rates as patients receive more appropriate care by following the established recommendations.

Arguments for adopting a wider use of CTA

From a C-suite perspective, the return on investment (ROI) for implementing cardiac CT includes several benefits. Cardiac CT makes patient care more efficient by aiding in the identification of patients who require cath lab procedures. It has been associated with a higher rate of percutaneous coronary intervention (PCI) cases, reducing the need for diagnostic catheterizations. This optimized use of cath labs leads to higher revenue generation, Biesbrock said.

Additionally, organizations that heavily utilize cardiac CT have higher revascularization rates. By identifying patients earlier and performing elective PCI procedures, she said the focus shifts from urgent, unstable cases to stable patients, resulting in cost savings and improved patient outcomes.

Overall, MedAxiom's research highlights the financial advantages of integrating cardiac CT into the cardiovascular service line, demonstrating how it positively impacts patient care, cath lab utilization and hospital operations. The data suggests that, despite the initial costs of implementing cardiac CT, the long-term benefits far outweigh the investment.

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."